Data & Analytics

Prescription drug spending rises 9% in 2015, to $324 billion

Prescription drug spending rises 9% in 2015, to $324 billion

By

However, the rate of drug spending slowed compared to last year, according to an analysis by the CMS.

U.S. marketers spend slightly less on digital engagement with docs than China

U.S. marketers spend slightly less on digital engagement with docs than China

By

A new survey found that U.S. pharma marketers prefer using social media and mobile apps to reach healthcare providers.

Infographic: The physician view on EHRs

Infographic: The physician view on EHRs

Most physicians said EHRs have negatively impacted their communication with a patients.

PulsePoint launches health vertical for programmatic advertising

PulsePoint launches health vertical for programmatic advertising

By

The programmatic advertising technology company also hired Chris Neuner as SVP and GM of digital health.

With more marketing spend behind it, Eliquis gains on market leader Xarelto

With more marketing spend behind it, Eliquis gains on market leader Xarelto

By

BMS and Pfizer outspent Johnson & Johnson two-to-one in advertising for their oral anticoagulant last year.

Best Use of Data/Analytics of 2016

Best Use of Data/Analytics of 2016

By

Judges praised Wunderman Health and GSK for their agility in reacting to dynamic information and creating segment-specific messaging for nasal spray allergy treatment Flonase.

Americans are increasingly critical of drug industry, a new poll finds

Americans are increasingly critical of drug industry, a new poll finds

By

A tracking poll conducted by the Kaiser Family Foundation also found that fewer Americans are seeing prescription drug ads compared to last year.

Mayo Clinic CEO John Noseworthy on the role of comms in healthcare

Mayo Clinic CEO John Noseworthy on the role of comms in healthcare

By

Mayo Clinic's CEO talks about how a trusted name in healthcare has evolved digitally and centered communications on its newsroom while retaining integrity.

MM&M's 5 most popular stories in September 2016

MM&M's 5 most popular stories in September 2016

By

Physicians are seeking beyond-the-pill services from drugmakers; Novartis debunks misconception that only smokers get lung cancer; pharma's access to docs declines

Discovering Meaningful Insights in Patient Journeys: Identifying Hidden Patterns Using Advanced Analytics

Discovering Meaningful Insights in Patient Journeys: Identifying Hidden Patterns Using Advanced Analytics

During this seminar, attendees will learn how advanced data analytics can be applied to gain a measurable competitive advantage.

Adherence: Leveraging Data to Enhance Your Brand's Ability to Reach Target Patients

Adherence: Leveraging Data to Enhance Your Brand's Ability to Reach Target Patients

In this webcast, TrialCard VP of analytic services Paul LeVine and senior analytic consultant Robert Leedom underscore how affordability programs provide the ideal venue for focusing on adherence issues.

Podcast: Adherence: Leveraging Data to Enhance Your Brand's Ability to Reach Target Patients

Podcast: Adherence: Leveraging Data to Enhance Your Brand's Ability to Reach Target Patients

In this sponsored podcast, MM&M's Larry Dobrow speaks with Robert Leedom, senior analytics consultant at TrialCard, and Paul LeVine, VP of analytic services for TrialCard, about how to reach patients by leveraging brand data.

Government watchdog finds that most but not all generic drug prices are falling

Government watchdog finds that most but not all generic drug prices are falling

By

A new government investigation found that most but not all prices for generic drugs dispensed by Medicare Part D fell from 2010 to 2015.

Report: 3 tips for pharma to provide beyond-the-pill services

Report: 3 tips for pharma to provide beyond-the-pill services

By

Physicians are seeking beyond-the-pill services from drugmakers, but few sales reps shares details with docs about these programs, a new report finds.

3 Lessons on Behavior Change from Pokémon Go

3 Lessons on Behavior Change from Pokémon Go

Jawbone data shows that people mentioning Pokémon Go in their comments have been walking 62.5% more than usual.

Expect healthcare agencies to make more digital acquisitions: report

Expect healthcare agencies to make more digital acquisitions: report

By

Mergers and acquisitions targeting digital and data capabilities increased 60% to $1 billion in the first half of 2016.

Five things for pharma marketers to know: Wednesday, July 27, 2016

Five things for pharma marketers to know: Wednesday, July 27, 2016

By

IBM to help analyze data about the spread of Zika; Grassley to investigate Part D program; Lilly CEO to retire

Five things for pharma marketers to know: Wednesday, July 20, 2016

Five things for pharma marketers to know: Wednesday, July 20, 2016

By By

Spending on CME rose in 2015; the FDA approves Valeant's Relistor; the Justice Department aims to block insurer merger

The Future of Data-Driven Marketing is Now

The Future of Data-Driven Marketing is Now

Healthcare marketing is evolving more rapidly than ever before — and not surprisingly, the demand for smarter media campaign measurement is increasing as a result.

No free lunch for docs: Sponsored meals linked to more prescriptions

No free lunch for docs: Sponsored meals linked to more prescriptions

By

A new analysis suggests that $20 industry-sponsored meals may sway docs' prescribing habits.

Panel: Why data is the first step in telling a human story

Panel: Why data is the first step in telling a human story

By

The ability to pair data with a story or a human emotion is often easier for women.

The CIO, reimagined for pharma

The CIO, reimagined for pharma

By

Despite the increasing importance of the CIO post, top technology professionals still find it hard to break into the uppermost ranks at life-sciences companies.

Pharma is reluctant to adopt digital in R&D: survey

Pharma is reluctant to adopt digital in R&D: survey

By

Only 55% of the surveyed pharmaceutical executives said they are adopting digital as a key strategy in R&D.

Five things for pharma marketers to know: Thursday, May 26, 2016

Five things for pharma marketers to know: Thursday, May 26, 2016

By

BIO report finds success rate in Phase-I is 10%; Dunsire departs Forum after failed trials; the FDA issues two warning letters

Conflicting polls highlight uncertainty about the public's opinion of pharma

Conflicting polls highlight uncertainty about the public's opinion of pharma

By

Two recent polls paint a complicated picture of the public's opinion of the pharma industry.

Five things for pharma marketers to know: Friday, May 20, 2016

Five things for pharma marketers to know: Friday, May 20, 2016

By

Keytruda's survival benefit is reinforced by new study; drugmakers reference patient-assistance programs in debate over drug prices; China cuts drug prices

Ponemon: Cybercrime is top cause for healthcare data breaches

Ponemon: Cybercrime is top cause for healthcare data breaches

A 69% majority of healthcare organizations said they believe their industry is more vulnerable to data breaches than other business sectors.

2016 Pharma Report: All the data in one place

2016 Pharma Report: All the data in one place

Learn more about the top therapeutic categories by sales, top companies by revenue, top drugs by sales, and more.

Do We Need Formal Surveys Anymore?

Do We Need Formal Surveys Anymore?

"Social can enable a better starting point to yield better questions and thus make surveys less in number yet greater in value."

Challenges exist, even as excitement grows for big data market

Challenges exist, even as excitement grows for big data market

By

The move away from a fee-for-service reimbursement model and the arrival of promising new technology have created demand for big data in healthcare.

OPINION

Email Newsletters